A long term trial with clofazimine in reactive lepromatous leprosy

H Plock et al. Lepr Rev. 1976 Mar.

. 1976 Mar;47(1):25-34.

doi: 10.5935/0305-7518.19760004.

No abstract available

Similar articles

Complications of treatment with clofazimine (Lamprene: B663).
Jopling WH. Jopling WH. Lepr Rev. 1976 Mar;47(1):1-3. doi: 10.5935/0305-7518.19760001. Lepr Rev. 1976. PMID: 1263731 No abstract available.
Clinical trial with clofazimine in leprosy.
Ganapati R, Dongre VV. Ganapati R, et al. Lepr India. 1976 Oct;48(4 Suppl):703-8. Lepr India. 1976. PMID: 1026807
Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy.
Rodriguez JN, Abalos RM, Reich CV, Tolentino JG. Rodriguez JN, et al. Int J Lepr Other Mycobact Dis. 1974 Jul-Sep;42(3):276-88. Int J Lepr Other Mycobact Dis. 1974. PMID: 4617715 No abstract available.
Clofazimine: a review of its use in leprosy and Mycobacterium avium complex infection.
Garrelts JC. Garrelts JC. DICP. 1991 May;25(5):525-31. doi: 10.1177/106002809102500513. DICP. 1991. PMID: 2068838 Review.
Lamprene (clofazimine) in leprosy. Basic information.
Yawalkar SJ, Vischer W. Yawalkar SJ, et al. Lepr Rev. 1979 Jun;50(2):135-44. doi: 10.5935/0305-7518.19790020. Lepr Rev. 1979. PMID: 396428 Review. No abstract available.

Interventions for erythema nodosum leprosum.
Van Veen NH, Lockwood DN, van Brakel WH, Ramirez J Jr, Richardus JH. Van Veen NH, et al. Cochrane Database Syst Rev. 2009 Jul 8;2009(3):CD006949. doi: 10.1002/14651858.CD006949.pub2. Cochrane Database Syst Rev. 2009. PMID: 19588412 Free PMC article.